Parkin polymorphisms and environmental exposure: Decrease in age at onset of Parkinson's disease

NeuroToxicology

Volumn 28, Issue 3, 2007, Pages 698-701

  Ghione, Isabella ^a   Di Fonzo, Alessio ^a   Saladino, Francesca ^a   Del Bo, Roberto ^a   Bresolin, Nereo ^a   Comi, Giacomo Pietro ^a   Rango, Mario ^a  

^a Centro Dino Ferrari   (Italy)

Author keywords

Age of onset of Parkinson's disease; Environmental risk factors for Parkinson's disease; Parkin polymorphisms

Indexed keywords

ALPHA SYNUCLEIN; LEVODOPA; PARKIN; PROTEIN PARK1; PROTEIN PARK2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EXON; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREMOR;

AGE OF ONSET; AGED; COHORT STUDIES; DNA; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; ITALY; MALE; MUTATION; PARKINSON DISEASE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UBIQUITIN-PROTEIN LIGASES;

EID: 34249808516     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2007.01.004     Document Type: Article

References (13)

1. In: Calne D., and Calne S.M. (Eds). Advances in neurology vol. 86 (2001), Lippincott Williams & Wilkins, Philadelphia 23-32
2. Hughes A.J., Ben- Shlomo Y., Daniel S.E., and Lees A.J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 42 (1992) 1142-1146
3. Hyun D.H., Lee M., Hattori N., et al. Effect of wild-type or mutant parkin on oxidative damage, nitric oxide, antioxidant defences, and the proteasome. J Biol Chem 277 (2002) 28572-28577
4. Jenner P. Oxidative mechanisms in nigral cell death in Parkinson's disease. Movement Disord 13 Suppl 1 (1998) 24-34
5. Kitada T., Asakawa S., Hattori N., et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392 (1998) 605-608
6. Klein C., Hedrich K., Wellenbrock C., Kann M., Harris J., Marder K., et al. Frequency of parkin mutations in late-onset Parkinson's disease. Ann Neurol 54 3 (2003) 415-416
7. Klein C. Implications of genetics on the diagnosis and care on the diagnosis and care of patients with Parkinson's disease. Arch Neurol 63 3 (2006) 328-334
8. Lohman E., Periquet M., Bonifati V., et al. How much phenotypic variation can be attributed to parkin genotype?. Ann Neurol 54 (2003) 176-185
9. Lücking C.B., Dürr A., Bonifati V., Vaughan J., De Michele G., Gasser T., et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med 342 (2000) 1560-1567
10. Oliveira S.A., Scott W.K., Martin E.R., Nance M.A., Watts R.L., Hubble J.P., et al. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Ann Neurol 53 (2003) 624-629
11. Rango M., Canesi M., Ghione I., Farabola M., et al. Parkinson's disease, chronic hydrocarbon exposure and striatal neuronal damage: a 1-H MRS study. Neurotoxicology 27 2 (2006) 164-168
12. Sherer T.B., Kim J.H., Betarbet R., and Greenamyre J.T. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and α-synuclein aggregation. Exp Neurol 179 (2003) 9-16
13. Warner T.T., and Schapira A.H. Genetic and environmental factors in the cause of Parkinson's disease. Ann Neurol 53 Suppl 3 (2003) S16-S23